Granules India Ltd.

NSE: GRANULES | BSE: 532482 | ISIN: INE101D01020 | Industry: Pharmaceuticals
| Mid-range Performer
467.5000 4.45 (0.96%)
NSE Apr 17, 2025 15:31 PM
Volume: 1.1M
 

467.50
0.96%
GEPL Capital
Granules India is a south based, fast growing global pharmaceutical company. GIL has presence across entire pharma value chain from Active Pharmaceutical Ingredients (APIs) to Pharmaceutical Formulation Intermediaries (PFIs) to Finished Dosages (FDs). It has a strong presence in first line of defense' products such as Paracetamol, Ibuprofen and Metformin. Currently, company has eight manufacturing facilities spread over India, China & US. Company operate in 75 countries, with over 300 customers across the globe & about 60% of...
Granules India Ltd. has an average target of 682.00 from 5 brokers.
More from Granules India Ltd.
Recommended